Vivanza Biosciences Limited announced a private placement of 3,136,000 fully convertible warrants on preferential basis to promoter group, and 1,600,000 fully convertible warrants on preferential basis to non-promoters on July 21, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.74 INR | +1.35% | -11.50% | -37.14% |
Apr. 30 | Vivanza Biosciences Limited Announces Directors Resignation | CI |
Apr. 30 | Vivanza Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-37.14% | 3.32M | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- VIVANZA6 Stock
- News Vivanza Biosciences Limited
- Vivanza Biosciences Limited announced a financing transaction